PGDx has the exclusive rights to develop both tissue- and blood-based diagnostics using MSK’s TMB-related intellectual property.
DNA Script has acquired an exclusive license to a novel DNA building block for use in enzymatic DNA synthesis.
The firm licensed two methods that help enrich for rare sequences in a complex background that it plans to use in cell-free DNA and microbiology tests.
Syngenta will be able to use the platform to evaluate, predict, compare, and select the best genetic makeup for crop molecular breeding and genomic selection.
The technology allows for genome-wide SNP discovery and genotyping in large populations of organisms in a single experiment.
GoPath has gained non-exclusive rights to commercialize a colorectal cancer test for the US and Canada based on IntegraGen's miR-31-3p biomarker.
The deal will accelerate delivery of high-quality, deidentified clinical databases to CancerLinQ, its oncologist subscribers, partners, and the broader cancer community.
Aldevron will manufacture IDT's patented S. pyogenes HiFi Cas9 mutant for research, clinical, and commercial uses.
Charles River said it will use the license to offer its customers a larger range of in vivo and in vitro genome editing services.
Expanding the companies' pre-existing agreement will allow Horizon to use CRISPR in new products and services.
The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.
A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.
Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.
In Science this week: analysis of DNA from ancient North Africans, and more.